Clinical trial

Effect of DPP4 Inhibition on Vasoconstriction

NCT02639637

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2015-12-01

PhasePHASE4

Study timeline

Study start (unknown)2015-12-01Date precision: month

Registry last updated2018-08-27

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type 2 Diabetes Mellitusverified · MONDO: type 2 diabetes mellitus

Interventions

SitagliptinDRUG · verified · RxNorm: sitagliptin

Neuropeptide YDRUG

EnalaprilatDRUG · verified · RxNorm: enalaprilat

Valsartan 160mgDRUG

Sponsors & collaborators

Vanderbilt Universitylead sponsor

Mapped research locations

NashvilleTennessee, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02639637 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.